A Comparative Effectiveness Study of Oral Medications Used for Migraine Prevention: The APT Comparison Study
PI(s): Todd Schwedt, Mayo Clinic Arizona; Juliana Vander Pluym, Mayo Clinic Arizona
Purpose: The goal of this study is to compare three medications used for migraine preventive treatment. This study will compare atogepant, a newer migraine preventive medication, with two older preventive medications, topiramate and propranolol. It will be determined if one works better and is more tolerable than the others.
Study Design: Interventional
PCORnet® Partners:
- STAR
PaTH Partners:
- Johns Hopkins University - Anne Damian Yacoub
- The Ohio State University - Kevin Weber
Sponsor: PCORI®
The The APT Comparison Study is a PCORnet® Study conducted using PCORnet®, the National Patient Centered Clinical Research Network, an initiative funded by the Patient-Centered Outcomes Research Institute (PCORI). More information about PCORnet® can be found here.
The The APT Comparison Study was funded by PCORI through PCORI Award MI-2023C2-33021.
The statements presented on this website are solely the responsibility of the author(s) and do not necessarily represent the views of other organizations participating in, collaborating with, or funding PCORnet or of PCORI.
Coordinating Center: Mayo Clinic Arizona
